Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Статистика рака в Китае и Соединённых Штатах, 2022 год: профили, тенденции и детерминанты
2022-02-09
SCID: 54.1/nvc2da48
Discuss with AI
Cancer burdenCancer incidence and mortalityCancer registry dataCase-fatality ratesPopulation aging
Figures from the paper
Abstract (AI)
BACKGROUND: The cancer burden in the United States of America (USA) has decreased gradually. However, China is experiencing a transition in its cancer profiles, with greater incidence of cancers that were previously more common in the USA. This study compared the latest cancer profiles, trends, and determinants between China and USA. METHODS: This was a comparative study using open-source data. Cancer cases and deaths in 2022 were calculated using cancer estimates from GLOBOCAN 2020 and population estimates from the United Nations. Trends in cancer incidence and mortality rates in the USA used data from the Surveillance, Epidemiology, and End Results program and National Center for Health Statistics. Chinese data were obtained from cancer registry reports. Data from the Global Burden of Disease 2019 and a decomposition method were used to express cancer deaths as the product of four determinant factors. RESULTS: In 2022, there will be approximately 4,820,000 and 2,370,000 new cancer cases, and 3,210,000 and 640,000 cancer deaths in China and the USA, respectively. The most common cancers are lung cancer in China and breast cancer in the USA, and lung cancer is the leading cause of cancer death in both. Age-standardized incidence and mortality rates for lung cancer and colorectal cancer in the USA have decreased significantly recently, but rates of liver cancer have increased slightly. Rates of stomach, liver, and esophageal cancer decreased gradually in China, but rates have increased for colorectal cancer in the whole population, prostate cancer in men, and other seven cancer types in women. Increases in adult population size and population aging were major determinants for incremental cancer deaths, and case-fatality rates contributed to reduced cancer deaths in both countries. CONCLUSIONS: The decreasing cancer burden in liver, stomach, and esophagus, and increasing burden in lung, colorectum, breast, and prostate, mean that cancer profiles in China and the USA are converging. Population aging is a growing determinant of incremental cancer burden. Progress in cancer prevention and care in the USA, and measures to actively respond to population aging, may help China to reduce the cancer burden.
Key Findings
1
Cancer profiles are converging in selected areas, with decreasing burdens for liver, stomach, and esophageal cancers and increasing burdens for lung, colorectal, breast, and prostate cancers.
2
In 2022, China was estimated to have 4,820,000 new cancer cases and 3,210,000 cancer deaths, compared with 2,370,000 cases and 640,000 deaths in the USA.
3
In China, stomach, liver, and esophageal cancer rates declined gradually, whereas colorectal cancer increased overall, prostate cancer increased in men, and seven other cancers increased in women.
4
In the USA, age-standardized incidence and mortality rates for lung and colorectal cancers recently declined significantly, while liver cancer rates increased slightly.
5
Lung cancer was the most common cancer in China, breast cancer was most common in the USA, and lung cancer led cancer mortality in both countries.
6
Population growth and aging were major drivers of increasing cancer deaths in both countries, while declining case-fatality rates reduced cancer mortality.
Research Object
Cancer burden and cancer profiles in China and the United States in 2022
Research Subject
Comparative temporal trends in cancer incidence and mortality and their determinants, including population growth, population aging, and case-fatality rates
Publication Details
Publication Date
2022-02-09
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20192020
Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study2020